Alexander L Greninger
Overview
Explore the profile of Alexander L Greninger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
352
Citations
9988
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adler A, Waghmare A, Lacombe K, Dickerson J, Greninger A, Briggs Hagen M, et al.
Microbiol Spectr
. 2025 Mar;
:e0262524.
PMID: 40062892
Seroprevalence studies play an important role in estimating the number of children infected with SARS-CoV-2. We report SARS-CoV-2 seroprevalence in children seeking medical care for any reason at a free-standing...
2.
Tran-Kiem C, Paredes M, Perofsky A, Frisbie L, Xie H, Kong K, et al.
Nature
. 2025 Mar;
PMID: 40044856
Pathogen genomics can provide insights into underlying infectious disease transmission patterns, but new methods are needed to handle modern large-scale pathogen genome datasets and realize this full potential. In particular,...
3.
Adler A, Waghmare A, Smith J, Kelton M, Dickerson J, Reed J, et al.
Pediatr Transplant
. 2025 Feb;
29(2):e70050.
PMID: 39992012
Background: Limited data are available regarding the development and durability of immune responses following COVID-19 infection or vaccination in pediatric solid-organ transplant (SOT) recipients. Methods: Renal, liver, or intestinal transplant...
4.
Luetkemeyer A, Chew K, Lacey S, Hughes M, Harrison L, Daar E, et al.
Clin Infect Dis
. 2025 Feb;
PMID: 39960062
Background: Ensitrelvir, a severe acute respiratory syndrome coronavirus-2 main protease inhibitor, has demonstrated clinical and virologic efficacy in previous studies. Methods: In this global phase 3 trial, nonhospitalized adults with...
5.
Mougari S, Favede V, Predella C, Reynard O, Durand S, Mazelier M, et al.
Commun Biol
. 2025 Jan;
8(1):57.
PMID: 39814955
We have assessed antiviral activity and induction of protective immunity of fusion-inhibitory lipopeptides derived from the C-terminal heptad-repeat domain of SARS-CoV-2 spike glycoprotein in transgenic mice expressing human ACE2 (K18-hACE2)....
6.
Yin P, Sobolik E, May N, Wang S, Fayed A, Vyshenska D, et al.
PLoS Pathog
. 2025 Jan;
21(1):e1012859.
PMID: 39804924
Chikungunya virus (CHIKV) is an arthritogenic alphavirus that has re-emerged to cause large outbreaks of human infections worldwide. There are currently no approved antivirals for treatment of CHIKV infection. Recently,...
7.
8.
Greninger A, Larcena A, Patel A, Webster B, Ulen C, Green D, et al.
J Clin Microbiol
. 2024 Nov;
62(12):e0121924.
PMID: 39503494
Importance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to cause millions of infections and tens of thousands of deaths per year in the United States. While the FDA authorized...
9.
Piliper E, Reed J, Greninger A
Microbiol Spectr
. 2024 Oct;
:e0211524.
PMID: 39470275
Importance: Population surveillance studies of serum-neutralizing activity against RSV are crucial for evaluating RSV vaccine efficacy and vulnerabilities to new strains. Here, we designed and validated a high-throughput assay for...
10.
Cox S, Casto A, Franko N, Chow E, Han P, Gamboa L, et al.
Emerg Infect Dis
. 2024 Oct;
30(11):2250-2260.
PMID: 39447143
Congregate homeless shelters are disproportionately affected by infectious disease outbreaks. We describe enterovirus epidemiology across 23 adult and family shelters in King County, Washington, USA, during October 2019-May 2021, by...